Industry Product Theater sessions
Exhibitors will present product-oriented demonstrations throughout the Annual Meeting.
See what’s new in the industry during product-oriented sessions taking place at the 2026 AAD Annual Meeting. These unique sessions give attendees the opportunity to view innovative products, research findings, and live demonstrations from exhibiting companies.
Industry Product Theater Sessions are located in the Exhibit Hall – Theaters 1 and 2. Additional session details are available in the AAD Meeting app. These sessions are solely promotional and are not eligible for CME credit.
View Industry Non-CME Programs here.
Friday, March 27
PRT01 – Latest Advances in Gene Expression Profiling (GEP) and GEP Guideline Updates for Cutaneous Melanoma
Presented by: SkylineDx USA, Inc.
10:30-11:15 a.m.
Exhibit Hall – Theater 1
PRT02 – Getting to the Core of EPP and XLP: Understanding, Diagnosing, and Managing Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP)
Presented by: DISC Medicine
11:15 a.m.-noon
Exhibit Hall – Theater 2
PRT03 – Innovations in Acne and Pigment Care: Therapeutic Photoprotection and the Synergy of Microneedling With Controlled Chemical Resurfacing
Presented by: CP Skin Health
Noon-12:45 p.m.
Exhibit Hall – Theater 1
PRT04 – Long-Term Disease Stability With Antibody Monotherapies in Moderate-to-Severe Atopic Dermatitis
Presented by: Lilly USA, LLC
12:45-1:30 p.m.
Exhibit Hall – Theater 2
PRT05 – Ablative Resurfacing Masterclass: Clinical Pearls for Superior Outcomes
Presented by: Lumenis
1:30-2:15 p.m.
Exhibit Hall – Theater 1
PRT06 – Raising the Bar
Presented by: AbbVie
2:15-3 p.m.
Exhibit Hall – Theater 2
PRT07 – Beyond Traditional RF: Safety and Efficacy of Everesse’s Innovative Water-Cooling System
Presented by: CLASSYS
3-3:45 p.m.
Exhibit Hall – Theater 1
PRT08 – Challenging the Watch-and-Wait Paradigm: Introducing ZelsuvmiTM (berdazimer) topical gel, 10.3%
Presented by: Pelthos Therapeutics
3:45-4:30 p.m.
Exhibit Hall – Theater 2
Saturday, March 28
PRT09 – Sailing Into Clear Horizons
Presented by: AbbVie
10:30-11:15 a.m.
Exhibit Hall – Theater 1
PRT10 – Evaluating the Rold of RoC Retinol in Skin Longevity
Presented by: RoC Skincare
11:15 a.m.-noon
Exhibit Hall – Theater 2
PRT11 – Explore Ebglyss (lebrikizumab-lbkz)
Presented by: Lilly USA, LLC
Noon-12:45 p.m.
Exhibit Hall – Theater 1
PRT13 – Drug-Like Cosmetics: How Prodrug Actives Are Game-Changers for Next-Gen Skin Care
Presented by: Dr. Mamina Turegano
1:30-2:15 p.m.
Exhibit Hall – Theater 1
PRT14 – Clinical Evaluation of a Novel Topical Gel to Support Post-Laser Skin Recovery
Presented by: Codex Labs Corp
2:15-3 p.m.
Exhibit Hall – Theater 2
PRT15 – Now Approved: A New Path Forward With Rhapsido (remibrutinib)
Presented by: Novartis Pharmaceuticals Corporation
3-3:45 p.m.
Exhibit Hall – Theater 1
PRT16 – Targeted Cellular Repair in Next-Generation Photoprotection
Presented by: Dr. Henry Lim
3:45-4:30 p.m.
Exhibit Hall – Theater 2
Sunday, March 29
PRT17 – Targeting the IL-31 Neuroimmune Pathway: A Case-Based Approach
Presented by: Galderma
10:30-11:15 a.m.
Exhibit Hall – Theater 1
PRT18 – Novel Discovery to Clinical Dermatology: Tregs in Inflammatory Skin Diseases
Presented by: Thermo Fischer Scientific
11:15 a.m.-noon
Exhibit Hall – Theater 2
PRT19 – A Product Theater for Taltz (ixekizumab) and Zepound (tirzepatide) Injection Including an Affordability Program for Eligible Taltz Patients Prescribed Zepbound
Presented by: Lilly USA, LLC
Noon-12:45 p.m.
Exhibit Hall – Theater 1
PRT20 – Illuminating the Inflammatory Prequel in Atopic Dermatitis
Presented by: Sanofi
12:45-1:30 p.m.
Exhibit Hall – Theater 2
PRT21 – AI for Dermatologists: Optimizing Clinical Workflows With Doximity GPT
Presented by: Doximity
1:30-2:15 p.m.
Exhibit Hall – Theater 1
